These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11894730)

  • 1. Inflammatory mediators in cystic fibrosis lung disease.
    Berger M
    Allergy Asthma Proc; 2002; 23(1):19-25. PubMed ID: 11894730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of inflammation in the pathophysiology of CF lung disease.
    Chmiel JF; Berger M; Konstan MW
    Clin Rev Allergy Immunol; 2002 Aug; 23(1):5-27. PubMed ID: 12162106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.
    Nichols D; Chmiel J; Berger M
    Clin Rev Allergy Immunol; 2008 Apr; 34(2):146-62. PubMed ID: 17960347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung inflammation as a therapeutic target in cystic fibrosis.
    Koehler DR; Downey GP; Sweezey NB; Tanswell AK; Hu J
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):377-81. PubMed ID: 15381503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and inflammatory mediators in cystic fibrosis.
    Courtney JM; Ennis M; Elborn JS
    J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
    Cantin AM; Hartl D; Konstan MW; Chmiel JF
    J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
    Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
    J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
    Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation.
    Chen J; Jiang XH; Chen H; Guo JH; Tsang LL; Yu MK; Xu WM; Chan HC
    J Cell Physiol; 2012 Jun; 227(6):2759-66. PubMed ID: 21913191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
    Bastonero S; Gargouri M; Ortiou S; Guéant JL; Merten MD
    J Gene Med; 2005 Nov; 7(11):1439-49. PubMed ID: 16001392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
    Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis.
    Morin C; Cantin AM; Rousseau É; Sirois M; Sirois C; Rizcallah E; Fortin S
    Am J Respir Cell Mol Biol; 2015 Oct; 53(4):574-83. PubMed ID: 25781052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring inflammation in CF. Cytokines.
    Sagel SD; Accurso FJ
    Clin Rev Allergy Immunol; 2002 Aug; 23(1):41-57. PubMed ID: 12162105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.